Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.67 |
| ▸ | CRHBP | P24387 | 1/20 | 0.67 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.67 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.67 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.62 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.62 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.62 |
| ▸ | F2 | P00734 | 1/20 | 0.61 |
| ▸ | F10 | P00742 | 1/20 | 0.61 |
| ▸ | PLG | P00747 | 1/20 | 0.61 |
| ▸ | PLAU | P00749 | 1/20 | 0.61 |
| ▸ | PLAT | P00750 | 1/20 | 0.61 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6796548 | 1.00 | MEN1 (0.67) | MEN1KMT2ATNNI3CRHBPTNNT2 | |
| SCHEMBL15421524 | 1.00 | MEN1 (0.67) | MEN1KMT2ATNNI3CRHBPTNNT2 | |
| SCHEMBL6795524 | 0.94 | ALDH1A1 (0.67) | MEN1KMT2ATNNI3CRHBPTNNT2 | |
| SCHEMBL6795520 | 0.94 | ALDH1A1 (0.67) | MEN1KMT2ATNNI3CRHBPTNNT2 | |
| SCHEMBL1241572 | 0.94 | ALDH1A1 (0.62) | MEN1KMT2ATNNI3CRHBPTNNT2 | |
| SCHEMBL6797935 | 0.89 | PLCG2 (0.67) | MEN1KMT2ATNNI3CRHBPTNNT2 | |
| SCHEMBL6797933 | 0.89 | PLCG2 (0.67) | MEN1KMT2ATNNI3CRHBPTNNT2 | |
| SCHEMBL11974092 | 0.88 | PLCG2 (0.78) | MEN1KMT2ATNNI3CRHBPTNNT2 | |
| SCHEMBL29518211 | 0.87 | CSNK2A2 (0.78) | MEN1KMT2ATNNI3CRHBPTNNT2 | |
| SCHEMBL22505155 | 0.87 | CSNK2A2 (0.78) | MEN1KMT2ATNNI3CRHBPTNNT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160102065-A1 | NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2016-04-14 | — | — | US | claimed |
| US-20040180943-A1 | Oxazolone analogs as amyloid aggregation inhibitors and for the treatment of alzheimer's disease and disorders related to amyloidosis | WARNER-LAMBERT COMPANY LLC | 2004-09-16 | — | — | US | claimed |
| US-4612388-A | Process for producing N-acylphenylalanines | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1986-09-16 | — | — | US | claimed |
| EP-3894914-B1 | OPHTHALMIC LENS COMPRISING AN OXAZOLONE | ESSILOR INT (FR) | 2023-11-22 | — | — | EP | disclosed |
| US-9896421-B2 | Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2018-02-20 | — | — | US | disclosed |
| US-20160102065-A1 | NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2016-04-14 | — | — | US | disclosed |
| US-9216148-B2 | Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use therefor | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2015-12-22 | — | — | US | disclosed |
| US-20140023603-A1 | NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2014-01-23 | — | — | US | disclosed |
| US-20040180943-A1 | Oxazolone analogs as amyloid aggregation inhibitors and for the treatment of alzheimer's disease and disorders related to amyloidosis | WARNER-LAMBERT COMPANY LLC | 2004-09-16 | — | — | US | disclosed |
| US-5087729-A | Sunscreen agents | AJINOMOTO CO., INC. (JP) | 1992-02-11 | — | — | US | disclosed |
| US-4985237-A | Benzylidene compounds, cosmetic compositions containing the same and ultraviolet absorber comprising the same | AJINOMOTO CO., INC. (JP) | 1991-01-15 | — | — | US | disclosed |
| EP-0161796-B1 | PROCESS FOR PRODUCING N-ACYLPHENYLALANINES | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-03-08 | — | — | EP | disclosed |
| US-4797493-A | ULTRAVIOLET RADIATION ABSORBERS TO PROTECT SKIN | AJINOMOTO CO., INC. (JP) | 1989-01-10 | — | — | US | disclosed |
| US-4612388-A | Process for producing N-acylphenylalanines | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1986-09-16 | — | — | US | disclosed |
| EP-0161796-A1 | Process for producing N-acylphenylalanines | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1985-11-21 | — | — | EP | disclosed |
| US-4281050-A | Migration imaging system | XEROX CORPORATION (US) | 1981-07-28 | — | — | US | disclosed |
| US-4007042-A | Migration imaging method | XEROX CORPORATION (US) | 1977-02-08 | — | — | US | disclosed |
| US-3989860-A | Repair technique for photoreceptors | XEROX CORPORATION (US) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140023603-A1 | NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR | PPARG, PPARA, PPARD | MEN1 4685/4885KMT2A 3139/4885TNNI3 1222/4885 |
| US-20040180943-A1 | Oxazolone analogs as amyloid aggregation inhibitors and for the treatment of alzheimer's disease and disorders related to amyloidosis | APP, PSEN1, PSEN2 | MEN1 2646/4885KMT2A 4782/4885TNNI3 2108/4885 |
| US-20160102065-A1 | NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF | PPARG, PPARA, TYR | MEN1 4838/4885KMT2A 2641/4885TNNI3 926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.